Leuko Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $60K

  • Investors
  • 23

Leuko General Information

Description

Developer of a home-based neutrophil test device designed to monitor and count white blood cells. The company's device is non-invasive sees through the skin also counts white blood cells and monitors patients' neutrophil levels ranging from chemotherapy management to the detection of life-threatening infections, enabling physicians to offer personalized chemotherapy and improve the survival rate of patients.

Contact Information

Website
www.leuko.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 678 Massachusetts Avenue
  • Suite 301
  • Cambridge, MA 02139
  • United States
+1 (781)
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Vertical(s)
Digital Health, HealthTech, Life Sciences, Oncology
Corporate Office
  • 678 Massachusetts Avenue
  • Suite 301
  • Cambridge, MA 02139
  • United States
+1 (781)

Leuko Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Leuko Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Grant 01-Jul-2025 $60K Completed Generating Revenue
15. Grant 24-Jul-2024 Completed Generating Revenue
14. Later Stage VC 01-Jul-2024 Completed Generating Revenue
13. Later Stage VC (Series A) 23-Sep-2022 Completed Generating Revenue
12. Later Stage VC 30-Jun-2022 Completed Generating Revenue
11. Grant 01-Jul-2020 Completed Generating Revenue
10. Later Stage VC 06-Mar-2020 Completed Generating Revenue
9. Accelerator/Incubator 01-Feb-2020 Completed Generating Revenue
8. Seed Round 18-Jul-2019 $1.74M $1.79M Completed Startup
7. Accelerator/Incubator 25-Jul-2018 $29.2K $49.2K Completed Startup
To view Leuko’s complete valuation and funding history, request access »

Leuko Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Leuko’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Leuko Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a home-based neutrophil test device designed to monitor and count white blood cells. The company's device i
Monitoring Equipment
Cambridge, MA
15 As of 2025

Hillsboro, OR
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Leuko Competitors (4)

One of Leuko’s 4 competitors is Modality Dx, a Venture Capital-Backed company based in Hillsboro, OR.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Modality Dx Venture Capital-Backed Hillsboro, OR
GlySure Formerly VC-backed London, United Kingdom
Sight Diagnostics Venture Capital-Backed Tel Aviv, Israel
GlySens Venture Capital-Backed San Diego, CA
To view Leuko’s complete competitors history, request access »

Leuko Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Leuko Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4362779-A1 Automated system and method for acquiring images of one or more capillaries in a capillary bed Pending 02-Aug-2021
EP-4362779-A4 Automated system and method for acquiring images of one or more capillaries in a capillary bed Pending 02-Aug-2021
US-20250013841-A1 Automated system and method for acquiring images of one or more capillaries in a capillary bed Pending 02-Aug-2021
WO-2023014629-A1 Automated system and method for acquiring images of one or more capillaries in a capillary bed Inactive 02-Aug-2021
US-12131217-B2 Automated system for acquiring images of one or more capillaries in a capillary bed Active 02-Aug-2021 G06K7/10732
To view Leuko’s complete patent history, request access »

Leuko Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Leuko Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Massachusetts eHealth Institute Government
Namarel Ventures Venture Capital Minority
Health Technology Holding Venture Capital Minority
JMC Family Office Family Office Minority
Little Green Bamboo Capital Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial

Leuko FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process